

Sanofi SA
(NASDAQ:SNY)
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. Just over 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
top performing SNY trades

Earl Blumenauer
House (D-OR)
8.80%

John James
House (R-MI)
-3.20%
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent Sanofi trades made by congress members.
![]() John JamesHouse (R-MI) | $1K - $15K | stock | Sale | Sep 06, 2024 | Sep 04, 2024 | House |
![]() John JamesHouse (R-MI) | $1K - $15K | stock | Purchase | Sep 02, 2024 | Nov 10, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $15K - $50K | stock | Sale | Aug 13, 2023 | Jul 10, 2023 | House |
![]() Daniel GoldmanHouse (D-NY) | $1K - $15K | stock | Sale (Partial) | Mar 20, 2023 | Feb 27, 2023 | House |
![]() Earl BlumenauerHouse (D-OR) | $15K - $50K | stock | Purchase | Jul 06, 2022 | May 27, 2022 | House |
![]() John RutherfordHouse (R-FL) | $1K - $15K | stock | Sale | Apr 19, 2022 | Mar 16, 2022 | House |